|
|
News Breaks | | | | January 23, 2013 | | 16:30 EDT |  | AGN, CREE, STRI, MAPP, HLF, MCP, COH, GOOG, FSLR, IBM | On The Fly: Closing Wrap
Stocks on Wall Street were higher following better than expected earnings from tech giants IBM (IBM) and Google (GOOG). Near midday, the House voted to extend the debt limit until May 19, as expected, and the markets did not react to the news. Eyes on the Street are focused on this evening's report from Nasdaq's largest component, Apple (AAPL)... ECONOMIC EVENTS: In the U.S., the light economic calendar included the Home Price Index, which showed prices rose 0.6% in November, versus expectations for an increase of 0.7%. Also of note, the International Monetary Fund lowered its outlook for 2013 global output growth to 3.5% from 3.6%... COMPANY NEWS: IBM shares gained $8.64, or 4.41%, to $204.72 after its earnings report and guidance exceeded expectations. Google similarly reported earnings that beat consensus. A number of firms increased their price targets on shares, including Jefferies taking their target up to $875. Google advanced $38.63, or 5.5%, to $741.50 following its earnings report... Herbalife (HLF) was again in the news as Greenlight Capital's quarterly letter to investors made the rounds this afternoon. There was some speculation that the letter contained a veiled reference to a short position in Herbalife, however, The Wall Street Journal reported that Greenlight's David Einhorn told investors he does not currently have any bet on the stock. However, Einhorn admitted to profiting from a short position in Herbalife held in 2012 that has since been closed. Shares of Herbalife were down $1.13, or 2.56%, to $43.01 on the day... Among notable companies moving after reporting earnings were Cree (CREE), up $7.38, or 22.05%, to $40.85 after beating expectations, and Coach (COH), down $9.93, or 16.36%, to $50.75 after its earnings fell short of expectations and its Q4 SSS fell 2%... MAJOR MOVERS: Among notable gainers was MAP Pharmaceuticals (MAPP), which rose $9.13, or 58.6%, to $24.71 after it was announced last night that the company had agreed to be acquired by Allergan (AGN) for $25 per share. Allergan shares fell $1.10, or 1.04%, to $104.65 following the announcement. Among notable losers was Molycorp (MCP), which fell 95c, or 10.76%, to $7.88 after disclosing that the company sees Q4 and 1H13 production below expectations and shares were downgraded at Dahlman Rose. Also lower were shares of STR Holdings (STRI), down 79c, or 25.48%, to $2.31 after announcing last night that it expects to lose First Solar (FSLR) as a customer and shares were downgraded to Hold at Craig-Hallum... INDICES: The Dow was up 66.96, or 0.49%, to 13,779.17; the Nasdaq was up 10.49, or 0.33%, to 3,153.67; and the S&P 500 was up 2.22, or 0.15%, to 1,494.78. | |
|
News For IBM;GOOG;HLF;CREE;COH;MAPP;AGN;MCP;STRI;FSLR From The Last 14 Days Check below for free stories on IBM;GOOG;HLF;CREE;COH;MAPP;AGN;MCP;STRI;FSLR the last two weeks. |
|
|
| June 19, 2013 | | 16:01 EDT |  | GOOG | Options Update; June 19, 2013
 Subscribe for More Information | | | 13:21 EDT |  | GOOG | Firefox maker to eliminate most Internet tracking, Washington Post says
Subscribe for More Information | | | 10:38 EDT | | GOOG | Samsung likely to reject idea of Facebook phone, Korea Herald says
Subscribe for More Information | | | 09:38 EDT | | GOOG | Active equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL AMAT FDX MA C GOOG DISH AMRN MRK BIDU | | | 08:58 EDT |  | GOOG | InvenSense likely shut out of iPhone this year, says Maxim
Subscribe for More Information | | | 08:56 EDT | | GOOG | Google price target raised to $1100 from $1000 at CLSA
Subscribe for More Information | | | 08:08 EDT | | GOOG | Merkel tells Obama: Internet monitoring must have proper limits, Reuters reports
Subscribe for More Information | | | 07:11 EDT | | GOOG | Google considers private-equity alliances for deals, Bloomberg reports
Subscribe for More Information | | | 06:44 EDT | | GOOG | Google relied on questionable exemption in Waze deal, NY Times says
Google decided not to provide the U.S. government with notice of its acquisition of Israeli mapping company Waze, The New York Times reported yesterday. The notice would have triggered a waiting period during which the government could review any antitrust issues created by the deal. Google relied on an exemption that waives the notice if a foreign company being acquired has sales and assets in the United States of less than $60.9M, the newspaper added. However, Waze's assets in the U.S. probably exceed that level, the Times stated. Reference Link | | | 06:08 EDT | | GOOG | On the Fly: Periodicals Wrap-Up
Subscribe for More Information | | | | June 18, 2013 | | 18:42 EDT | | GOOG | Google files court petition related to NSA surveillance, CNNMoney says
Google has filed a First Amendment court case demanding it be allowed to share information about government surveillance programs with the public, CNNMoney reports. Reference Link | | | 17:12 EDT |  | GOOG | Nvidia to begin licensing GPU cores, visual computing portfolio
Subscribe for More Information | | | 13:33 EDT | | HLF | Pershing Square: Herbalife's new survey, statements raise questions of legality
Subscribe for More Information | | | 09:38 EDT | | GOOG | Active equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL NFLX GOOG PFE TSLA MGM | | | 09:15 EDT | | FSLR | China to generate more heat using solar energy, China Daily says
Subscribe for More Information | | | 09:04 EDT |  | AGN | Wells Faro to host a conference
2013 Healthcare Conference is being held in Boston on June 18-19 with webcasted company presentations to begin at 8:15 am; not all company presentations may be webcasted. Webcast Link | | | 08:36 EDT | | AGN | Elan shares could be worh $19 in a buyout, says Jefferies
Jefferies raised its price target for shares of Elan (ELN) to $19 from $14, reflecting what it sees as the value of the company in a takeout scenario. The firm says Elan management suggested they would be open to sale in the $15-$20 per share range. Jefferies believes a high taxpaying suitor could pay the upper end of that range, and lists Allergan (AGN), Regeneron (REGN), Vertex (VRTX), Alexion (ALXN), Zoetis (ZTS), Mylan (MYL) and Perrigo (PRGO) as potential acquirers for Elan. Shares of Elan are up 13c to $13.62 in pre-market trading after Royalty Pharma announced that its buyout proposal for the company has expired. | | | 07:42 EDT | | GOOG | O'Reilly Media to hold a conference
Subscribe for More Information | | | 07:35 EDT | | CREE | Cree LED bulbs still most popular at Home Depot, says Susquehanna
Subscribe for More Information | | | 07:29 EDT | | GOOG, IBM | Securities Industry and Financial Markets Association to host a conference
Subscribe for More Information | | |
|
|
|
|
|
|
